XAIR

Beyond Air, Inc.
—

Company Information

Company Name
Beyond Air, Inc.
CIK
CIK0001641631
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
XAIR: Nasdaq
Fiscal Year End
March 31
Owner Organization
08 Industrial Applications and Services
SIC
3841
SIC Description
Surgical & Medical Instruments & Apparatus
Ticker
XAIR

SEC filing data through

Insider Sentiment

Last purchase
2026-07-29
Last sale
2023-12-28
Shares purchased (TTM)
39,062
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
1,354,874
Shares outstanding
721,328
Ownership
187.83%

Earnings Market Reaction

Filing date
2026-08-13
Price on filing date
—
1-month reaction
-48.99%
3-month reaction
…
Drift continued9/11 (82%)
Faded / reversed2/11 (18%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value6771055528411813
Marketable Securities Current4551126-17232325
Restricted Cash Current566000000005
Accounts Receivable Net Current111111110000
Inventory Net112222232222
Prepaid Expense And Other Assets Current555556566761
Assets Current232526191516193831443947
Finite Lived Intangible Assets Net----------12
Finite Lived License Agreements Gross1111111111--
Operating Lease Right Of Use Asset111222222222
Property Plant And Equipment Net88991011121212997
Other Assets Noncurrent000000000000
Assets333537312830345347575258
Liabilities Current
Accounts Payable Current222212213233
Accrued Liabilities Current----------88
Accrued Liabilities And Other Liabilities4322323488--
Operating Lease Liability Current000000000000
Loans Payable Current00--01001100
Liabilities Current7754555712121212
Operating Lease Liability Noncurrent111111222222
Long Term Loans Payable22222210109-1115151414
Other Liabilities Noncurrent---22-------
Derivative Liabilities Noncurrent--0-----0100
Liabilities302928181816162429302829
Stockholders Equity
Common Stock Value-000-0000000
Treasury Stock Value-0-0-0-0-0-0-0-0-0-0-0-0
Additional Paid In Capital329326317315304300296293268265247235
Retained Earnings Accumulated Deficit-328-320-309-302-294-286-278-265-252-240-226-210
Accumulated Other Comprehensive Income Loss Net Of Tax00000-0-000-000
Stockholders Equity268131014182918272129
Minority Interest100001112233
Liabilities And Stockholders Equity333537312830345347575258
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized101010101010101010101010
Preferred Stock Shares Issued000000000000
Preferred Stock Shares Outstanding000000000000
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized500500500500500500100100100500100100
Common Stock Shares Issued110000442222
Shares Outstanding110000442222

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Beyond Air, Inc. (XAIR) — SEC Financial Statements & Analysis

Beyond Air, Inc. (XAIR) is a surgical & medical instruments & apparatus company, incorporated in DE. Beyond Air, Inc. trades on Nasdaq as: XAIR. Beyond Air, Inc. (XAIR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Beyond Air, Inc. carries a market cap of $6.43M, a P/E ratio of -0.19x, a P/B ratio of 3.22x, a P/S ratio of 0.84x, an enterprise value of $1.16M, and an EV/EBITDA multiple of -0.05x. On profitability, it posts a gross margin of 4.18%, an operating margin of -364.76%, a net margin of -435.71%, a Return on Equity (ROE) of -561.77%, a Return on Assets (ROA) of -109.80%, and a Return on Invested Capital (ROIC) of -559.42%. Per share, it reports EPS of $-46.43, diluted EPS of $-46.43, free cash flow per share of $-27.17, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 60.75% year-over-year, net income growth of -18.83% year-over-year, and EPS growth of -71.78% year-over-year. On the balance sheet, it maintains a current ratio of 3.31x, a quick ratio of 2.37x, working capital of $15.94M, a debt-to-equity ratio of 15.05x, a debt ratio of 0.91, an interest coverage ratio of -6.29x, free cash flow of $-19.60M (TTM), and net debt of $-5.28M. Figures sourced from SEC EDGAR.

Market Cap
$6.43M
P/E TTM
-0.19x
EPS TTM
$-46.43
P/B TTM
3.22x
ROE TTM
-561.77%
ROA TTM
-109.80%
Debt To Equity
15.05x
Free Cash Flow TTM
$-19.60M
Net Revenue TTM Growth 1Y
60.75%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Beyond Air, Inc. in?

Beyond Air, Inc. (XAIR) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does XAIR trade on?

Beyond Air, Inc. (XAIR) trades on the Nasdaq.

Where is Beyond Air, Inc. incorporated?

Beyond Air, Inc. is incorporated in DE.

When was Beyond Air, Inc. (XAIR)'s most recent SEC filing?

Beyond Air, Inc. (XAIR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.

What is XAIR's market cap?

Beyond Air, Inc. (XAIR) has a market capitalization of $6.43M as of 2026-06-30.

What is XAIR's EPS (earnings per share)?

Beyond Air, Inc. (XAIR)'s trailing twelve month EPS is $-46.43 as of 2026-06-30.

What is XAIR's ROE (return on equity)?

Beyond Air, Inc. (XAIR)'s trailing twelve month Return on Equity (ROE) is -561.77% as of 2026-06-30.

What is XAIR's ROA (return on assets)?

Beyond Air, Inc. (XAIR)'s trailing twelve month Return on Assets (ROA) is -109.80% as of 2026-06-30.

What is XAIR's ROIC (return on invested capital)?

Beyond Air, Inc. (XAIR)'s trailing twelve month Return on Invested Capital (ROIC) is -559.42% as of 2026-03-31.

What is XAIR's EV/EBITDA?

Beyond Air, Inc. (XAIR)'s trailing twelve month EV/EBITDA is -0.05x as of 2026-06-30.

Wall Street's data.
Main Street's price.